TrialPanorama/TrialPanorama-database huggingface dataset:
Study 23962028 — Predictive Biomarker (PRD): Hormone receptor
Study 10737482 — Surrogate Endpoint (SUR): Blood pressure
Study 30670251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27827397 — Surrogate Endpoint (SUR): Blood pressure
Study 23312562 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 23312562 — Safety Biomarker (SAF): BDNF
Study 7702230 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7702230 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12559241 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 29735021 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 20619382 — Predictive Biomarker (PRD): CD81 mRNA
Genes: CD81; TAPA1; TSPAN28
Study 12708964 — Safety Biomarker (SAF): Reactive oxygen species
Study 6978687 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 29893003 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 1913714 — Surrogate Endpoint (SUR): Blood pressure
Study 29373687 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16572737 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 31036412 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31036412 — Surrogate Endpoint (SUR): Blood pressure
Study 19914604 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study 21095620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21095620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8804929 — Predictive Biomarker (PRD): TAC1 mRNA
Genes: TAC1; NKA; NKNA; TAC2
Study 6368960 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 23535332 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 9297313 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9297313 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 9297313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31488492 — Predictive Biomarker (PRD): SQSTM1 mRNA
Genes: SQSTM1; ORCA; OSIL
Study 28817434 — Predictive Biomarker (PRD): PTMS mRNA
Genes: PTMS
Study 24144899 — Surrogate Endpoint (SUR): Bone mineral density
Study 2447516 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 2447516 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 15809365 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 1683250 — Surrogate Endpoint (SUR): Blood pressure
Study 22204725 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29231339 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26551272 — Surrogate Endpoint (SUR): Blood pressure
Study 21555684 — Predictive Biomarker (PRD): Hormone receptor
Study 10901185 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study 18558026 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9301443 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 9301443 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9301443 — Safety Biomarker (SAF): Interleukin 1
Study 24397879 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 22422589 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 18672531 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1503287 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 27792720 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17586424 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28785809 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study 28785809 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study 28785809 — Safety Biomarker (SAF): miR-181a
Study 28785809 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study 19175712 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 10393617 — Surrogate Endpoint (SUR): Bone mineral density
Study 31382005 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 15870641 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15870641 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 12000487 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 2487533 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2487533 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 648206 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31788828 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 24084214 — Surrogate Endpoint (SUR): Blood pressure
Study 24084214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24084214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18197403 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 18197403 — Surrogate Endpoint (SUR): Blood pressure
Study 28793919 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 24016502 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 21099666 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18236463 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 15265847 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9280211 — Surrogate Endpoint (SUR): Blood pressure
Study 10967150 — Surrogate Endpoint (SUR): Blood pressure
Study 1437342 — Predictive Biomarker (PRD): PRPH2 mRNA
Genes: PRPH2; PRPH; RDS; TSPAN22
Study 3885671 — Surrogate Endpoint (SUR): Serum triglycerides
Study 29738817 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 28033320 — Surrogate Endpoint (SUR): Blood pressure
Study 17283177 — Predictive Biomarker (PRD): APEX1 mRNA
Genes: APEX1; APE; APE1; APEX; APX; HAP1; REF1
Study 17283177 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 11465585 — Surrogate Endpoint (SUR): Blood pressure
Study 7878692 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29643011 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28858440 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 25851628 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25851628 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 25851628 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 25851628 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 25851628 — Predictive Biomarker (PRD): Hormone receptor
Study 21446378 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 21446378 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 8587426 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study 8587426 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 20526759 — Safety Biomarker (SAF): Reactive oxygen species
Study 15683753 — Predictive Biomarker (PRD): ADRA2C mRNA
Genes: ADRA2C; ADRA2L2; ADRA2RL2
Study 12854503 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 1682683 — Surrogate Endpoint (SUR): Blood pressure
Study 24374068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 17852017 — Surrogate Endpoint (SUR): Forced vital capacity
Study 12351591 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 9690802 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 21810897 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 21810897 — Predictive Biomarker (PRD): AGTR1 mRNA
Genes: AGTR1; AGTR1A; AGTR1B; AT2R1; AT2R1B
Study 21810897 — Predictive Biomarker (PRD): AGTR2 mRNA
Genes: AGTR2
Study 21810897 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 3100910 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30582156 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 22446297 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 17610900 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1724390 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 24714660 — Surrogate Endpoint (SUR): Serum calcium
Study 31641887 — Surrogate Endpoint (SUR): Blood pressure
Study 24807156 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24807156 — Predictive Biomarker (PRD): NRP1 mRNA
Genes: NRP1; NRP; VEGF165R
Study 24807156 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24807156 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 20195952 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20195952 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 20195952 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 17263884 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 17263884 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1752914 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 6810204 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 28281736 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 3107374 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 25525163 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 25525163 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 16137195 — Predictive Biomarker (PRD): XRCC3 mRNA
Genes: XRCC3
Study 24132814 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 19330493 — Surrogate Endpoint (SUR): Blood pressure
Study 27653813 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 27653813 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24065259 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 15220015 — Surrogate Endpoint (SUR): Blood pressure
Study 11558859 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 11558859 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11558859 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23617089 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 9365092 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 9365092 — Surrogate Endpoint (SUR): Bone mineral density
Study 9365092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24946635 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 9449392 — Surrogate Endpoint (SUR): Blood pressure
Study 7653442 — Surrogate Endpoint (SUR): Blood pressure
Study 31307434 — Predictive Biomarker (PRD): STUB1 mRNA
Genes: STUB1; CHIP; PP1131
Study 24664189 — Surrogate Endpoint (SUR): Blood pressure
Study 23318311 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 3732093 — Surrogate Endpoint (SUR): Blood pressure
Study 26716656 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 24574351 — Surrogate Endpoint (SUR): Blood pressure
Study 25986159 — Surrogate Endpoint (SUR): Blood pressure
Study 25509258 — Monitoring Biomarker (MOI): HBV DNA
Study 22287641 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 18257772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1737543 — Predictive Biomarker (PRD): TNFRSF10A mRNA
Genes: TNFRSF10A; APO2; DR4; TRAILR1
Study 30244844 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18835953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17786067 — Surrogate Endpoint (SUR): Blood pressure
Study 14638340 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 31064361 — Surrogate Endpoint (SUR): Blood pressure
Study 19430350 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study 16963731 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 24357853 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10478142 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 10478142 — Surrogate Endpoint (SUR): Bone mineral density
Study 1917320 — Surrogate Endpoint (SUR): Blood pressure
Study 31892336 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31892336 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31892336 — Predictive Biomarker (PRD): PERP mRNA
Genes: PERP; KCP1; KRTCAP1; PIGPC1; THW
Study 31892336 — Predictive Biomarker (PRD): YWHAQ mRNA
Genes: YWHAQ
Study 31892336 — Predictive Biomarker (PRD): SAP130 mRNA
Genes: SAP130
Study 31892336 — Predictive Biomarker (PRD): HDAC4 mRNA
Genes: HDAC4; KIAA0288
Study 31892336 — Predictive Biomarker (PRD): NCOA7 mRNA
Genes: NCOA7; ERAP140; ESNA1; Nbla00052; Nbla10993
Study 31892336 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 31892336 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study 31892336 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 31892336 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 19365873 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 2492893 — Safety Biomarker (SAF): Biliary glycoprotein 1
Genes: CEACAM1; BGP; BGP1
Study 2492893 — Surrogate Endpoint (SUR): Serum calcium
Study 4851464 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 23341486 — Surrogate Endpoint (SUR): Bone mineral density
Study 21697540 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 29567956 — Safety Biomarker (SAF): IL-6 and IL-10
Study 2359302 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 26787505 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22437139 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 7720336 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 8636520 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 27764781 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 27764781 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 3917702 — Surrogate Endpoint (SUR): Blood pressure
Study 23059790 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 22093120 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26359996 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 30287610 — Surrogate Endpoint (SUR): Blood pressure
Study 27052961 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16699827 — Surrogate Endpoint (SUR): Blood pressure
Study 24943000 — Surrogate Endpoint (SUR): Blood pressure
Study 23031516 — Predictive Biomarker (PRD): MCAT mRNA
Genes: MCAT; MT
Study 23031516 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 23031516 — Safety Biomarker (SAF): Cytochrome c
Study 18448618 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 27552171 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 27552171 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 12594142 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 1422322 — Safety Biomarker (SAF): Biliary glycoprotein 1
Genes: CEACAM1; BGP; BGP1
Study 1422322 — Surrogate Endpoint (SUR): Bone mineral density
Study 4074607 — Surrogate Endpoint (SUR): Blood pressure
Study 27936941 — Surrogate Endpoint (SUR): Blood pressure
Study 12589354 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 26329980 — Surrogate Endpoint (SUR): Blood pressure
Study 18193377 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 16644440 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 8872851 — Surrogate Endpoint (SUR): Blood pressure
Study 29505803 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 25541919 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study 19947262 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 19947262 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8688342 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9103468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24338947 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 22569436 — Surrogate Endpoint (SUR): Serum potassium
Study 15675576 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 10445304 — Surrogate Endpoint (SUR): Blood pressure
Study 27860267 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 27860267 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9670986 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8168039 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 31077751 — Surrogate Endpoint (SUR): Blood pressure
Study 25878120 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 12508146 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 12508146 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 11789188 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11789188 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 2056774 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 26769830 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 26769830 — Safety Biomarker (SAF): BDNF
Study 24268861 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 21121981 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 21121981 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 19415672 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19415672 — Surrogate Endpoint (SUR): Blood pressure
Study 25290104 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21480731 — Surrogate Endpoint (SUR): Blood pressure
Study 25061313 — Predictive Biomarker (PRD): CRTAP mRNA
Genes: CRTAP; CASP
Study 25061313 — Surrogate Endpoint (SUR): Blood pressure
Study 21862331 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 21862331 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21862331 — Predictive Biomarker (PRD): Hormone receptor
Study 25381471 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study 9222726 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 8228209 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 8228209 — Surrogate Endpoint (SUR): Blood pressure
Study 3630597 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26928904 — Surrogate Endpoint (SUR): Blood pressure
Study 22744655 — Surrogate Endpoint (SUR): Blood pressure
Study 12528106 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 10373769 — Surrogate Endpoint (SUR): Blood pressure
Study 27845562 — Surrogate Endpoint (SUR): Bacterial count
Study 31087075 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study 19834333 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19834333 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 11876713 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7602352 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 29763951 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 25766081 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25766081 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9778007 — Surrogate Endpoint (SUR): Blood pressure
Study 31815582 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 16829707 — Surrogate Endpoint (SUR): Blood pressure
Study 16829707 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27422893 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 8790560 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 8790560 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 28919200 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 12768289 — Predictive Biomarker (PRD): NAT8 mRNA
Genes: NAT8; CML1; GLA; TSC501
Study 1519637 — Surrogate Endpoint (SUR): Blood pressure
Study 30281397 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study 25233856 — Surrogate Endpoint (SUR): Serum creatinine
Study 12398872 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 12398872 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 12398872 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10464707 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 10464707 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29924771 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27145207 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11688001 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 11688001 — Surrogate Endpoint (SUR): Serum creatinine
Study 8233265 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11781274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2